BRIEF published on 05/31/2024 at 11:05, 5 months 21 days ago Lübke Kelber AG Publishes Annual Financial Statements for 2023 Financial Statements EBIT Annual Results Equity Increase Lübke Kelber AG
PRESS RELEASE published on 05/31/2024 at 11:00, 5 months 21 days ago Lübke Kelber AG publishes annual financial statements for 2023 Lübke Kelber AG announces the publication of their 2023 annual financial statements following the inclusion of Dr. Lübke & Kelber GmbH, with details on revenues, EBIT, net loss, and equity Revenues Annual Financial Statements EBIT Equity Lübke Kelber AG
BRIEF published on 05/10/2024 at 10:52, 6 months 11 days ago Lübke Kelber AG Releases Preliminary Financial Results for 2023 Financial Results Real Estate 2023 EBIT Lübke Kelber AG
PRESS RELEASE published on 05/10/2024 at 10:47, 6 months 11 days ago Lübke Kelber publishes preliminary figures for the 2023 financial year Lübke Kelber AG announces preliminary figures for the 2023 financial year, revealing increased equity and sales, with a planned positive EBIT for 2024 2023 Financial Year Preliminary Figures Equity Increase Lübke Kelber AG Positive EBIT
Published on 11/21/2024 at 13:30, 22 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 22 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 52 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 52 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 52 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 17 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 37 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 54 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 32 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 7 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 7 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
